A 70-year-old man with longstanding hypertension and diabetes presents with gradual worsening of bilateral lower limb swelling and breathlessness. Echocardiogram shows left ventricular ejection fraction 25%. He is already on optimal doses of ACE inhibitor, beta blocker and mineralocorticoid receptor antagonist. According to heart failure management principles, which additional class of drug has strong evidence for improving outcomes?